Web Analytics

3 Latest Announced Rounds

  • $10,500,000
    Series A

    6 Investors

    Chemical Manufacturing
    Nov 15th, 2024
  • $3,000,000
    Pre-Seed

    1 Investors

    Software Development
    Nov 15th, 2024
  • $1,600,000
    Pre-Seed

    3 Investors

    Software Development
    Nov 15th, 2024
$1,512.09M Raised in 74 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Panome Bio

start up
United States - Saint Louis, MO
  • 16/03/2023
  • Unknown
  • Undisclosed Amount

Panome Bio can help you profile and discover biomarkers with our Next-Generation Metabolomics capabilities, comprehensive workflows and personalized data analysis reports.

Our Next-Generation Metabolomics platform is making major advancements in the metabolism field by going beyond pairwise comparisons and making complex experiments with large and complicated datasets possible. Cutting-edge technology and computational methods are used to extract only the biologically-relevant chemical compounds to give you a clearer view of phenotype. We provide a global and unbiased view of the metabolome through a suite of complementary LC/MS assays that captures the breadth of diverse metabolites in biological systems.

We have the ability to complement your metabolomics data with proteomics to better understand pathways and metabolism through our partnership with Somalogic. Somalogic’s SomaScan® 7K Assay is a high-throughput proteomics assay that screens 7,000 proteins per sample simultaneously.


Related People

Edward WeinsteinCo Founder

Edward Weinstein United States - St Louis, Missouri

N/A